Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...

VMD response to concerns raised following media reports of serious adverse events in cats administered Solensia. The VMD is aware of media reports and ...

This article will cover two common attack vectors against large language models and tools based on them, prompt injection and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The new Bimzelx administration and dosage is ...

is now commercially available by prescription in the United States in a 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX The single-injection device offers convenience ...

UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX® (bimekizumab-bkzx) is now available. These ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

Genentech unit has received FDA approval for its drug Susvimo 100 mg/mL injection for the treatment of diabetic macular edema, a leading cause of blindness for people with diabetes. Susvimo, also ...

insurance may not cover injection supplies, a person may not have insurance, or the pharmacy may only stock one syringe size (for example: 3 mL instead of 1 mL) and may make substitutions based on ...

Necropsy and pathological analysis were performed on d87 and d116 (after recovery for 29 days). Recombinant human FGF-21 for injection (batch number: 20150101) and its vehicle (10 mL/tube and 120 ...

New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...